Literature DB >> 3065633

Detection of individual virus-infected cells by filter in situ hybridization.

B Forbes1, L Gissmann, M Pawlita.   

Abstract

The diagnosis of virus infection by nucleic acid hybridization represents an alternative to classical virological diagnostic methods. One special technique termed 'filter in situ hybridization' consists of fixation of intact cells to nitrocellulose filters followed by hybridization with a labelled DNA probe. We demonstrate that filter in situ hybridization can be a simple and sensitive method for the detection of virus infection in cells. In an in vitro model system using a human B-lymphoma cell line infected by the lymphotropic papovavirus (LPV), it is shown that individual virus replicating cells can be detected by this method. Infection can be diagnosed even if only one out of 20,000 cells in a culture contains replicating virus. This assay may be of value as a diagnostic tool in other viral systems.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3065633     DOI: 10.1016/0890-8508(88)90008-4

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  3 in total

1.  Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree.

Authors:  L Ho; S Y Chan; V Chow; T Chong; S K Tay; L L Villa; H U Bernard
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

2.  The cell surface receptor is a major determinant restricting the host range of the B-lymphotropic papovavirus.

Authors:  G Haun; O T Keppler; C T Bock; M Herrmann; H Zentgraf; M Pawlita
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

3.  Regulation of susceptibility and cell surface receptor for the B-lymphotropic papovavirus by N glycosylation.

Authors:  O T Keppler; M Herrmann; M Oppenländer; W Meschede; M Pawlita
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.